epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

Journal Article Synopsis

ECO 2026

16h

GLP-1s spare muscle, but less so than diet, exercise

Most of what patients shed is fat and relative muscle mass holds up, but proportionally more lean tissue is lost than with diet and exercise interventions. . .

Journal Article Synopsis

Lancet Psychiatry

17h

Most antidepressants in pregnancy show no autism, ADHD link

A meta-analysis of 37 studies covering more than 600,000 antidepressant-exposed pregnancies found that small associations with autism and ADHD disappeared once researchers accounted for parental mental health and shared family factors. . .

Journal Article Synopsis

ECO 2026

17h

Childhood obesity care nonresponders lose weight on semaglutide

Young adults with childhood-onset severe obesity that had resisted years of structured pediatric care saw meaningful BMI reductions and broad metabolic gains on weekly semaglutide, with treatment effect independent of prior response. . .

Journal Article Synopsis

Stroke

18h

Prior heart attack linked to faster cognitive decline

Heart attack survivors showed faster decline on memory and thinking tests than people without a history of myocardial infarction. . .

Journal Article Synopsis

JAMA Pediatr

18h

Medicaid expansion cut dialysis deaths in young adults

Young adults starting dialysis were more likely to receive predialysis nephrology care, longer dialysis sessions, and peritoneal dialysis after Affordable Care Act Medicaid expansion. . .

Government Health Agency News

FDA

19h

FDA expands Vyvgart and Vyvgart Hytrulo approval in generalized myasthenia gravis

Vyvgart and Vyvgart Hytrulo are now approved for all adult gMG serotypes, including MuSK-positive, LRP4-positive, and triple seronegative disease. . .

Journal Article Synopsis

JAMA Psychiatry

19h

Adjunctive antipsychotics rank differently for efficacy and tolerability

A network meta-analysis found meaningful differences in efficacy, acceptability, and tolerability among FDA-approved atypical antipsychotics used adjunctively for major depressive disorder. . .

Journal Article Synopsis

ECO 2026

20h

GLP-1s tied to fewer asthma issues, less inhaler use

Adults with asthma who started a GLP-1 receptor agonist had 26% fewer exacerbations and 14% lower reliever inhaler use in the year after starting treatment, in a nationwide Danish cohort. . .

Journal Article Synopsis

ECO 2026

20h

European obesity guideline: pair GLP-1s with nutrition, muscle, mental health

Obesity experts, dietitians, and patient advocacy groups issue joint guidance calling for dietitian-led nutrition therapy, body composition monitoring, and psychological screening for patients on incretin-based weight-loss drugs. . .

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information